Franck Rahaghi, MD

Franck Rahaghi, MD, MH, FCCP, is Chair of Quality at Cleveland Clinic Florida Hospital and Clinic. He has also been Medical Director of the Respiratory Care Department since 2003.

In 2003, Dr. Rahaghi became Staff Attending in Pulmonary Critical Care as well as Director of the Pulmonary Hypertension Clinic, Cleveland Clinic Florida. In 2005, he became Head of the Pulmonary Education and Rehabilitation Department as well as a member of the Internal Review Board, responsible for correct conduct of research and clinical trials at Cleveland Clinic Florida. In the following year, he was named Director of Quality and Outcomes Development in the Division of Medicine.

Formerly, Dr. Rahaghi was a Fellow in Medicine/Pulmonary/Critical Care at New York Presbyterian-Weill Cornell Medical Center in New York City (1999-2003). He was also an Instructor in genetic medicine at the Cornell University Weill School of Medicine (2001-2003) and assisted in the design and implementation of clinical trials at Cornell (Activated Protein C and IFN gamma-1b) (2000-2003).

In 1999, he was a Visiting Associate Physician at Rockefeller University Hospital, New York, N.Y. He participated in the Categorical Internal Medicine Program at the University of Illinois at Chicago from 1997-1999. From 1996-1997, he participated in the Categorical Internal Medicine Program.at the University of Minnesota, Minn. In 2000, he became a Hospitalist at Sharp Memorial Hospital, San Diego. The following year, he was a Visitor at the University of California-San Diego Interventional Pulmonology Department/Pulmonary Hypertension.

Education & Professional Highlights

Appointed
2003

Additional Training

Enhancing Team Effectiveness, professional development program for health professions faculty, jointly sponsored by the Association of American Medical Colleges and Harvard Medical School
Cleveland Clinic Leadership Course, Cleveland Clinic, 2006
Advanced Training in Quality, American College of Executive Physicians

Professional Highlights

Expert in pulmonary hypertension, serving South Florida (Broward and Palm Beaches)
Head of the first comprehensive Pulmonary Education Department
Chair of Quality in Cleveland Clinic Florida, advancing outcome-based improvements in quality

Certifications

Internal Medicine - Pulmonary Disease

Specialty Interests

pulmonary hypertension, Alpha-1 anti-trypsin deficiency/COPD, interstitial lung diseases, including: collagen vascular diseases (Scleroderma) and pulmonary fibrosis, Sarcoidosis, critical care

Awards & Honors

Innovator Award, Cleveland Clinic, for innovation in medical technology, 2005-2007
Leadership Certificate, Cleveland Clinic (promising future leaders at Cleveland Clinic), 2006
Fellow, American College of Chest Physicians, 2005
Cornell Award for Best Fellow Research, 2004

Innovations & Patents

Convertible dual-lumen endotracheal tube: U.S. Patent Pending, 2005

Memberships

College of Chest Physicians
Society of Critical Care Medicine
Pulmonary Hypertension Association/Research
American Medical Association
American Society of Executive Physicians,Vanguard Member

Research & Publications

See publications for Franck Rahaghi, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 6/23/2024, Dr. Rahaghi has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Rahaghi receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

Ani Pharmaceuticals, Inc.
Takeda Pharmaceuticals North America, Inc.
Janssen Pharmaceuticals, Inc.
Boehringer Ingelheim
Mallinckrodt, plc
United Therapeutics Corporation

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Primary Location

Cleveland Clinic Weston Hospital

Treatment & Services

Specialty in Diseases & Conditions

Insurance

Is Cleveland Clinic Florida Part of Your Insurance?

About Franck Rahaghi, MD